Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of SAR156597 in the Treatment of Diffuse Cutaneous Systemic Sclerosis (dcSSc): A Randomized, Double-blind, Placebo-controlled, 24-week, Proof of Concept Study

NCT02921971 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02921971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02921971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of SAR156597 in the Treatment of Diffuse Cutaneous Systemic Sclerosis (dcSSc): A Randomized, Double-blind, Placebo-controlled, 24-week, Proof of Concept Study
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
December 21, 2016
Completion date
April 1, 2019
Enrollment
97 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis